Inaccordance with Joint Accreditation criteria and the ACCME’s Standards forIntegrity and Independence in Accredited Continuing Education, the Associationof Diabetes Care & Education Specialists (ADCES) must ensure that anyone ina position to control the content of the educational activity (planners andspeakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.
Joint Accreditation/ACCME also requires that ADCES mitigate any reported conflict and eliminate the potential for bias during the educational activity. The disclosure information is intended to identify any ineligible relationships and allow learners to form their own judgments. However, if you perceive a bias during an activity, please report it on the evaluation.
Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:Speakers
No speakers involved in this activity have any conflicts to disclose.Planners
Marissa Grossman, Education Manager, Medical Learning Insititute, Inc., Conflict(s): Stabiliz Ortopaedics (Stock)
Jodi Lavin-Tompkins, MSN, RN, CDCES, BC-ADM, Director of Accreditation/Content Development, ADCES, Conflict(s): Gilead Sciences, Regeneron Pharma (Stock, relationship ended)
Michael R. Page, PharmD, RPh, Medical Director, Med Learning Group, Conflict(s): American Medical Communications; BioCentric, Inc (Consultant)
Disclosure and Mitigation of Relevant Conflicts of Interest
All identified relevant conflicts of interest have been mitigated.
The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.
Medical Learning Institute
This activity is supported by an educational grant from Lilly.